|
|
| (2 intermediate revisions by 2 users not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Adenosine#How Supplied]] |
| {{Adenosine}}
| |
| {{CMG}}; {{AE}} {{AZ}}
| |
| | |
| ==How Supplied==
| |
| Adenocard® (adenosine injection) is supplied as a sterile non-pyrogenic solution in normal saline.
| |
| NDC 0469-8234-12 Product Code 823412
| |
| 6 mg/2 mL (3 mg/mL) in 2 mL (fill volume) Ansyr® plastic disposable syringe, in a package of ten.
| |
| NDC 0469-8234-14 Product Code 823414
| |
| 12 mg/4 mL (3 mg/mL) in 4 mL (fill volume) Ansyr® plastic disposable syringe, in a package of ten.
| |
| Store at controlled room temperature 15º-30ºC (59º-86ºF).
| |
| '''DO NOT REFRIGERATE''' as crystallization may occur. If crystallization has occurred, dissolve crystals by warming to room temperature. The solution must be clear at the time of use.
| |
| Contains no preservatives. Discard unused portion.
| |
| May require needle or blunt. To prevent needle-stick injuries, needles should not be recapped, purposely bent or broken by hand.
| |
| Rx Only<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ADENOCARD (ADENOSINE) SOLUTION [ASTELLAS PHARMA US, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f0e32589-dad9-4887-8481-bcf7f6618466 | publisher = | date = | accessdate = }}</ref>
| |
| | |
| ==References==
| |
| {{Reflist}}
| |
| | |
| {{FDA}}
| |
| | |
| [[Category:Drugs]]
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Drugs]]
| |
| [[Category:Antiarrhythmic agents]]
| |